Our results revealed that treatment with OTS167 decreased the TOPK protein level in SCLC cells (Figure 4C) as well as the transcriptional level of TOPK (Supplementary Figure 4) (*p < 0.05, **p < 0.01). The gene discussed is PBK; the disease is small cell lung carcinoma.